| 摘要 |
The present invention relates to physically improved tablet formulations of a leukotriene receptor antagonist and combinations of the leukotriene receptor antagonist with an H1- antihistaminic which are effective in prevention and/or treatment of allergic and inflammatory diseases of the skin or upper and lower respiratory tracts and relieving the symptoms thereof. |
